VEGFA and central nervous system cancer: Nimotuzumab had also shown to downregulate vascular endothelial growth factor (VEGF) expression and to inhibit angiogenesis after treatment in A431 squamous cell carcinoma xenografts 16, as well as in U87MG glioma xenografts in combination with radiotherapy 17.